← Evidence map

ReviewCancers2026

Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies.

Ismini Tsagkaraki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41899515